Skip to content

Alveolar Cleft Reconstruction Using Bone Marrow Aspirate Concentrate and Allograft vs Iliac Cancellous Bone.

Alveolar Cleft Reconstruction Using BMAC and Allograft vs Iliac Cancellous Bone: A Randomized Clinical Trial.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06356870
Acronym
BMAC
Enrollment
20
Registered
2024-04-10
Start date
2024-06-01
Completion date
2026-06-01
Last updated
2024-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Cleft Grafting

Keywords

BMAC, alveolar cleft

Brief summary

radiographic and clinical assessment of alveolar cleft grafting using Allograft mixed with BMAC compared to the standard protocol of anterior iliac crest cancellous bone grafting

Detailed description

In the study group BMAC is collected after processing of bone marrow aspirated from anterior iliac crest using a stab incision and a specialized trocar with no surgical intervention at donor site. The BMAC will be mixed with allow graft and used for alveolar cleft grafting In the control group the standard protocol for alveolar cleft grafting will be used which is surgical exposure of the anterior iliac crest and harvesting of cancellous bone particles.

Interventions

PROCEDUREBMAC MIXED WITH ALLOGRAFT

Study group

PROCEDURECancellous bone from anterior iliac crest

Control group

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

parallel assignment

Eligibility

Sex/Gender
ALL
Age
8 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* alveolar cleft patients at the mixed dentition phase

Exclusion criteria

* patients with previous alveolar grafting intervention

Design outcomes

Primary

MeasureTime frameDescription
bone density6 monthsAssessment of bone density at the grafting site from a CT scan using Hounsfild Unit (HU)

Secondary

MeasureTime frameDescription
Bone gain6 monthsAssessment of bone gain at the grafting site from a CT scan in millimeters
Postoperative donor site morbidity1 monthAssessment of donor site morbidity with a questionnaire (VAS Score)

Countries

Egypt

Contacts

Primary ContactAhmed M Abdelmaksoud
ahmedmostafa10@hotmail.com01092490609

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026